Drug Profile
Research programme: prolyl hydroxylase inhibitors - FibroGen
Alternative Names: FG 4497; FG 4539; Research programme: HIF prolyl hydroxylase inhibitors - FibroGenLatest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator FibroGen
- Class Small molecules
- Mechanism of Action Hypoxia-inducible factor-proline dioxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cerebral ischaemia; Ischaemia; Kidney disorders; Obesity; Sickle cell anaemia; Stroke; Wounds
Most Recent Events
- 28 Mar 2022 No recent reports of development identified for preclinical development in Cerebral-ischaemia in USA (PO)
- 28 Mar 2022 No recent reports of development identified for preclinical development in Ischaemia in USA (PO)
- 28 Mar 2022 No recent reports of development identified for preclinical development in Kidney-disorders(Prevention) in USA (PO)